The NPC is a strategic collaboration of leading research groups from several Dutch universities, research institutes and academic medical centres. The core of the consortium consists of the following formal participants:

• Utrecht University (UU)
• University Medical Centre Utrecht (UMCU)
• University of Groningen (RUG)
• Leiden University (LU)
• Leiden University Medical Centre (LUMC)
• Delft University of Technology (TU Delft)
• Radboud University Nijmegen (RUN)
• University of Amsterdam (UvA)
• Academic Medical Centre Amsterdam (AMC)
• Wageningen University and Research Centre/Plant Research International (WUR/PRI)
• Erasmus Medical Centre Rotterdam (Erasmus MC)
• Netherlands Cancer Institute (NKI)
• Netherlands Vaccin Institute (NVI)
• FOM Institute AMOLF
• Hubrecht Institute

• Agilent Technologies Inc.
• Bayer Crop Sciences, Germany
• Bruker Daltonics
• CatchMabs
• Chordiant (NL)
• Crossbeta Biosciences
• Crucell
• Da Vinci Europe
• Diagenode
• DMV International
• DSM Food Specialties
• Friesland Foods
• Fujirebio Diagnostics, Sweden
• GeneBio SA
• Genencor
• Genmab
• IBM, NJ, VS
• IMP Vienna
• Invitrogen
• IRIS Biotech GmbH
• LC Packings/Dionex
• Macrozyme
• Merck, VS
• Numico
• Organon
• P.A.L.M., Duitsland
• Pamgene
• Pepscan (NL)
• Pharma Bioresearch
• Philips
• RIKILT
• Roche Penzberg (G)
• Semaia Pharmaceuticals
• Solvay Pharmaceuticals
• Thermo Electron
• TNO
• Upper Austrian Research Company, Oostenrijk